-
Could a new combined oral contraceptive (OC) be available to U.S. women? Organon is conducting two Phase 3a trials for the first monophasic oral contraceptive containing estradiol (E2) and a new progestin, nomegestrol acetate (NOMAC).
-
Review the number of sexually transmitted diseases (STDs) detected in your patient population over the last year.
-
New research indicates that a rapid test that uses self-collected vaginal swabs may be effective in diagnosing chlamydia.1 With its ability to deliver results in less than 30 minutes, the test, now in development, would give clinicians a same-day diagnostic and screening tool for chlamydial infection.
-
While you may be comfortable with menstrual suppression through use of continuous oral contraceptives (OCs), are your patients? According to results from a national survey, more than 66% of women say that they are interested in suppressing their menstrual periods, but many of them aren't sure if it's safe.
-
What is your level of knowledge when it comes to genital herpes, its methods of virus transmission, risks to others, and appropriate treatment? If results of an online survey are any indication, many health care providers and patients with herpes are poorly informed about herpes.
-
While women have several options when it comes to birth control, men are limited to condoms and vasectomies. Researchers around the globe are focusing efforts to expand those choices, including hormonal injections, gels, and implants.
-
Do you still recommend that women use backup contraception when prescribed antibiotics during oral contraceptive use? If you do, it's time to check your approach, according to information presented at the Contraceptive Technology conference.
-
Despite intense screening in the past decade, higher rates of cervical cancer persist in Hispanic women.1 How can you reach these women with the information they need for prevention and detection?
-
Has the telephone been ringing in your office with questions from patients who are concerned about using oral contraceptives in light of media reports questioning the Pill's safety? If so, you are not alone. What are you doing to help women place such news in proper context?
-
It's time to increase chlamydia screening in your clinic. Results of a new study show that, despite current screening recommendations, more than 2 million people are infected with chlamydia in the United States.
